Inogen | INGN - Current Assets


Inogen reported $203.72M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Accuray USD 292.39M 11.22M Dec/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Artivion USD 371.38M 13.86M Jun/2026
AtriCure USD 345.53M 31.84M Jun/2026
Baxter International USD 6.99B 142M Jun/2026
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Boston Scientific USD 7.97B 712M Jun/2026
Cooper Companies USD 2.3B 166M Mar/2026
Dexcom USD 4.09B 245.1M Jun/2026
Edwards Lifesciences USD 6.82B 590.2M Jun/2026
Globus Medical USD 2.22B 17.39M Jun/2026
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.85B 139.6M Jun/2026
Medtronic USD 24.79B 716M Mar/2026
Orthofix International USD 446.13M 15.39M Jun/2026
Philips EUR 9.33B 454M Jun/2026
ResMed USD 4.32B 260.68M Jun/2026
Steris USD 2.45B 51.2M Jun/2026
Stryker USD 14.42B 1.08B Jun/2026
Tandem Diabetes Care USD 804.64M 82.46M Jun/2026
Teleflex USD 1.88B 16.21M Jun/2026
X T L Biopharmaceuticals USD 166K 367K Dec/2025
Zimmer Biomet Holdings USD 5.1B 134.2M Jun/2026